Are Patients Traveling for Intraoperative Radiation Therapy?

Table 1

Comparison of patients who live local (<50 miles), regional (50–100 miles), and faraway from the treating institution.

	Local patients (<50 miles) (68.7%)	Regional patients (50–100 miles) (11.3%)	Faraway patients (>100 miles) (20.0%)	value
Mean travel distance (miles)	19.8	70.0	500.6	<0.001
Age (years)	71.3	71.8	68.6	0.28
Race
Caucasian	90 (90%)	17 (100%)	27 (93.1%)	0.34
African American	8 (8%)	0	0 (0%)
Asian	1 (1%)	0	1 (3.5%)
Other	1 (1%)	0	1 (3.5%)
Tumor type
IDC	63 (61.2%)	11 (64.7%)	17 (56.7%)	0.41
ILC	4 (3.8%)	0	1 (3.3%)
Mixed	35 (34.0%)	5 (29.4%)	10 (33.3%)
Other	1 (1%)	1 (5.9%)	2 (6.6%)
ER positive	103 (100%)	17 (100%)	29 (96.7%)	0.31
PR positive	88 (85.4%)	15 (88.2%)	27 (93.1%)	0.59
HER2 positive	1 (1%)	0	0	0.34
Adjuvant chemotherapy	0	0	4 (14.3%)	0.002
Whole breast radiation	2 (2%)	0	1 (3.6%)	0.67

<0.05 = significant.